HemaSphere
(Jun 2022)
PB1765: EFFICACY OF A NEW INDUCTION REGIMEN IN THE TREATMENT OF EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA.
- M. Wang,
- J. Rao,
- Q. Wen,
- G. Chen,
- X. Tan,
- Y. Ma,
- L. Gao,
- L. Gao,
- P. Kong,
- C. Zhang,
- X. Zhang
Affiliations
- M. Wang
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- J. Rao
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- Q. Wen
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- G. Chen
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- X. Tan
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- Y. Ma
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- L. Gao
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- L. Gao
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- P. Kong
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- C. Zhang
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- X. Zhang
- 1 Medical center of hematology, Xinqiao hospital, Army medical university, Chongqing, China
- DOI
-
https://doi.org/10.1097/01.HS9.0000849916.02538.70
- Journal volume & issue
-
Vol. 6
pp.
1646
– 1647
WeChat QR code